Baricitinib for Depression in Male Football Players
JAK Signaling in Depression and Cognition in Male Football Players
- Age
- 30 – 55
- Sex
- Male
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 30 (estimated)
- Sponsor
- Emory University · Other
This trial is looking for men aged 30-55 who have played tackle football for at least 11 years and are experiencing depression. Participants will take a medication called baricitinib to help understand its effect on their symptoms.
You may be able to join if
- I am male.
- I have played tackle football for at least 11 years.
- I am between 30 and 55 years old.
- I have been diagnosed with major depression or bipolar, depressed type.
- I have a PHQ-9 score over 10.
- I am off all antidepressant medications for at least 4 weeks.
- My CRP level is 3 mg/L or higher.
- I have a score of 2 or more on specific PHQ-9 items.
You may not be able to join if
- I have a current or past autoimmune disorder.
- I have a history of hepatitis B or C, or HIV.
- I have had cancer that needed more than minor surgery.
- I have unstable heart, hormone, blood, liver, kidney, or brain disease.
- I have a history of deep vein thrombosis.
- I have had major surgery in the last 6 months.
- I have an active or recent infection.
- I have cirrhosis of the liver.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 11 years of organized tackle football. This will be evaluated using a medication called baricitinib, which blocks one aspect of inflammation.
Loading trial locations…